ReviewCancers2025

Ex-Vivo Drug-Sensitivity Testing to Predict Clinical Response in Non-Small Cell Lung Cancer and Pleural Mesothelioma: A Systematic Review and Narrative Synthesis.

Jenny Zipprick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.